Metropolis launches AI-powered allergy component testing for various allergy types – ET HealthWorld
Mumbai: Metropolis Healthcare Limited announced the launch of a novel testing platform based on Component Resolved Diagnostics (CRD) to support India’s population in diagnosing various forms of allergies. The fourth-generation allergy testing technology uses artificial intelligence (AI) to assist clinicians in making sound clinical decisions and provides great insights into selecting and optimising the course … Read more